Revising You the Staging for Pancreatic Cancer in 2012

  • Muhammad Wasif Saif Columbia University College of Physicians and Surgeons. New York, NY, USA
DOI: https://doi.org/10.6092/1590-8577/717
Keywords: Blood Vessels, General Surgery, Neoplasm Staging, Pancreas, Pancreatic Neoplasms

Abstract

No abstract available.

Downloads

Download data is not yet available.

References

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.

Surveillance Epidemiology and End Results (SEER). U.S. Cancer Statistics: 1999-2007 Incidence and Mortality Report. Available at http://www.seer.cancer.gov/publications/uscs.html (Accessed January 31, 2012)

Saif MW. Controversies in the adjuvant treatment of pancreatic adenocarcinoma. JOP. J Pancreas (Online) 2007; 8:545-52.

Kim R, Saif MW. Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer? JOP. J Pancreas (Online) 2007; 8:279-88.

Saif MW. Is there a standard of care for the management of advanced pancreatic cancer? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008. JOP. J Pancreas (Online) 2008; 9:91-8

Exocrine and endocrine pancreas. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 241-9.

Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, Evans DB. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 1996; 12:373-80.

National Comprehensive Cancer Network, Inc (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Pancreatic Adenocarcinoma Version 2.2012. Fort Washington, PA, USA: National Comprehensive Cancer Network, Inc (NCCN), 2012. http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf

Pimiento JM, Hutchinson T, Weber JM, Patel MR, Hodul PJ, Chuong MD, et al. Multimodality therapy for borderline resectable pancreatic cancer: A single-institution experience. J Clin Oncol 30, 2012 (suppl 4; abstr 280)

Chakraborty S, Bauer TW, Morris MM, Yarde E, Parsons JT, Adams RB, Sanoff HK. Accelerated fraction radiotherapy with concomitant capecitabine as neoadjuvant therapy of borderline resectable pancreatic cancer. J Clin Oncol 30, 2012 (suppl 4; abstr 329)

Papavasiliou P, Piposar JR, Arrangoiz R, Chen KT, Zhu F, Chun YS, Hoffman JP. Margin status and neoadjuvant chemoradiation in patients with borderline resectable pancreatic cancer. J Clin Oncol 30, 2012 (suppl 4; abstr 304)

Ashman JB, Moss AA, Callister MD, Reddy KS, Mulligan DC, Gunderson LL, Borad MJ. Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma. J Clin Oncol 30, 2012 (suppl 4; Abstr 327)

The Pancreas Center
Published
2012-03-10
How to Cite
SaifM. (2012). Revising You the Staging for Pancreatic Cancer in 2012. JOP. Journal of the Pancreas, 13(2), 128-130. https://doi.org/10.6092/1590-8577/717
Issue
Vol 13 No 2 (2012): March - p. 124-251
Section
EDITORIALS

Copyright (c) 2014 Muhammad Wasif Saif

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.